Karyopharm Therapeutics
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell KPTI and other ETFs, options, and stocks.About KPTI
Karyopharm Therapeutics, Inc. is a commercial-stage pharmaceutical company, which engages in the discovery, development, and commercialization of drugs directed against nuclear export for the treatment of cancer and other diseases. The company was founded by Joseph Araujo, Ronald A.
KPTI Key Statistics
Stock Snapshot
Karyopharm Therapeutics(KPTI) stock is priced at $0.39, giving the company a market capitalization of 8.69M. It carries a P/E multiple of -0.03.
On 2026-10-18, Karyopharm Therapeutics(KPTI) stock moved within a range of $0.33 to $0.45. With shares now at $0.39, the stock is trading +18.3% above its intraday low and -13.0% below the session's peak.
Trading volume for Karyopharm Therapeutics(KPTI) stock has reached 2.71M, versus its average volume of 1.46M.
The stock's 52-week range extends from a low of $0.31 to a high of $10.99.
The stock's 52-week range extends from a low of $0.31 to a high of $10.99.
Analyst ratings
83%
of 6 ratingsPeople also own
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.